These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20221611)

  • 1. A retrospective study of infections after primary VP shunt placement in the newborn with myelomeningocele without prophylactic antibiotics.
    Clemmensen D; Rasmussen MM; Mosdal C
    Childs Nerv Syst; 2010 Nov; 26(11):1517-21. PubMed ID: 20221611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting infection development after meningomyelocele repair in newborns and the efficacy of antibiotic prophylaxis.
    Demir N; Peker E; Gülşen İ; Ağengin K; Tuncer O
    Childs Nerv Syst; 2015 Aug; 31(8):1355-9. PubMed ID: 25870027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of dual procedures: How combining VP shunt placement for hydrocephalus and myelomeningocele repair in newborns affects complication rates?
    Kadri H; Agha MS; Abouharb R; Mackieh R; Bakleh S; Almasri M; Kadri T
    Neurosurg Rev; 2024 Jul; 47(1):343. PubMed ID: 39031287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection in myelomeningocele after VP shunt placement.
    Radmanesh F; Nejat F; El Khashab M
    Childs Nerv Syst; 2011 Mar; 27(3):341-2; author reply 343-4. PubMed ID: 21210126
    [No Abstract]   [Full Text] [Related]  

  • 5. The Effectiveness of Antibiotic-Coated Ventriculoperitoneal Shunts for Prevention of Shunt Infections in Patients with Myelomeningocele.
    Ertuğrul B; Kaplan M; Batu Hergünsel Ö; Akgün B; Öztürk S; Serhat Erol F
    Pediatr Neurosurg; 2021; 56(4):357-360. PubMed ID: 34034264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of the need for cerebrospinal fluid diversion in patients with myelomeningocele.
    Phillips BC; Gelsomino M; Pownall AL; Ocal E; Spencer HJ; O'Brien MS; Albert GW
    J Neurosurg Pediatr; 2014 Aug; 14(2):167-72. PubMed ID: 24877604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shunt revision rates in myelomeningocele patients in the first year of life: a retrospective study of 52 patients.
    Alatas I; Canaz G; Kayran NA; Kara N; Canaz H
    Childs Nerv Syst; 2018 May; 34(5):919-923. PubMed ID: 29159427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reviewing the prognostic factors in myelomeningocele.
    Protzenko T; Bellas A; Pousa MS; Protzenko M; Fontes JM; de Lima Silveira AM; Sá CA; Pereira JP; Salomão RM; Salomão JFM; Dos Santos Gomes SC
    Neurosurg Focus; 2019 Oct; 47(4):E2. PubMed ID: 31574474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shunt infection and malfunction in patients with myelomeningocele.
    White MD; McDowell MM; Agarwal N; Greene S
    J Neurosurg Pediatr; 2021 May; 27(5):518-524. PubMed ID: 33636695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of postoperative antibiotic injection in and around ventriculoperitoneal shunt in reduction of shunt infection: A randomized controlled trial.
    Moussa WM; Mohamed MA
    Clin Neurol Neurosurg; 2016 Apr; 143():144-9. PubMed ID: 26945767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association between the Timing of Shunt Placement and Shunt Infection in Hydrocephalus Associated with Myelomeningocele.
    Gurbuz MS; Yuksel MO
    Turk Neurosurg; 2020; 30(1):94-98. PubMed ID: 31452179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shunt insertion in newborns with myeloschisis/myelomenigocele and hydrocephalus.
    Yilmaz A; Müslüman AM; Dalgic N; Cavuşoğlu H; Kanat A; Colak I; Aydın Y
    J Clin Neurosci; 2010 Dec; 17(12):1493-6. PubMed ID: 20869250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postsurgical infection after myelomeningocele repair: a multivariate analysis of 60 consecutive cases.
    Schroeder HK; Nunes JC; Madeira L; Moritz JL; Walz R; Linhares MN
    Clin Neurol Neurosurg; 2012 Sep; 114(7):981-5. PubMed ID: 22425366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of External Ventricular Drainage to Reduce the Frequency of Wound Complications in Myelomeningocele Closure.
    McDowell MM; Lee PS; Foster KA; Greene S
    Pediatr Neurosurg; 2018; 53(2):100-107. PubMed ID: 29316543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shunt complications in children with myelomeningocele: effect of timing of shunt placement. Clinical article.
    Radmanesh F; Nejat F; El Khashab M; Ghodsi SM; Ardebili HE
    J Neurosurg Pediatr; 2009 Jun; 3(6):516-20. PubMed ID: 19485738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of ventriculoperitoneal shunt insertion following spina bifida closure in Kenya.
    Margaron FC; Poenaru D; Bransford R; Albright AL
    Childs Nerv Syst; 2010 Nov; 26(11):1523-8. PubMed ID: 20422197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple method to reduce infection of ventriculoperitoneal shunts.
    Rehman AU; Rehman TU; Bashir HH; Gupta V
    J Neurosurg Pediatr; 2010 Jun; 5(6):569-72. PubMed ID: 20515328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When should ventriculoperitoneal shunt placement be performed in cases with myelomeningocele and hydrocephalus?
    Oktem IS; Menkü A; Ozdemir A
    Turk Neurosurg; 2008 Oct; 18(4):387-91. PubMed ID: 19107685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of ventriculoperitoneal shunt infections due to gastrostomy feeding tube insertion in pediatric patients with brain tumors.
    Gassas A; Kennedy J; Green G; Connolly B; Cohen J; Dag-Ellams U; Kulkarni A; Bouffet E
    Pediatr Neurosurg; 2006; 42(2):95-9. PubMed ID: 16465078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventriculoperitoneal shunt infections in patients with hydrocephalus.
    Simpkins CJ
    Pediatr Nurs; 2005; 31(6):457-62. PubMed ID: 16411537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.